Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
20.9M
-
Number of holders
-
147
-
Total 13F shares, excl. options
-
23.4M
-
Shares change
-
+1.93M
-
Total reported value, excl. options
-
$886M
-
Value change
-
+$1.34M
-
Put/Call ratio
-
1.2
-
Number of buys
-
79
-
Number of sells
-
-95
-
Price
-
$37.87
Significant Holders of Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) as of Q1 2025
210 filings reported holding PRAX - Praxis Precision Medicines, Inc. - COMMON STOCK as of Q1 2025.
Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) has 147 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.4M shares
.
Largest 10 shareholders include Cormorant Asset Management, LP (1.75M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.74M shares), JANUS HENDERSON GROUP PLC (1.51M shares), BlackRock, Inc. (1.42M shares), MORGAN STANLEY (1.21M shares), Soleus Capital Management, L.P. (1.14M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.1M shares), VANGUARD GROUP INC (1.09M shares), VR ADVISER, LLC (990K shares), and PERCEPTIVE ADVISORS LLC (981K shares).
This table shows the top 147 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.